| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3625b5ab897f31dc2fee1237fb406972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9ffcf35803e278511309477f079f2c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eea6c6e7b5664c1f2767c5a3e5920735 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-12022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e3b76dc87d8fb05b3a55e3275b09de3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_887e47efa021155a88300f468732c6bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_820ea43c04a10c222b370fd345f5aa6a |
| publicationDate |
2022-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022042993-A1 |
| titleOfInvention |
Betaretrovirus epitopes and related methods of use |
| abstract |
Methods for determination of risk, previous history and/or presence of a betaretrovirus infection in a subject are described herein. Said methods may comprise incubating a biological sample from the subject, the biological sample comprising immune effector-producing cells, with one or more betaretrovirus-specific epitopes, the betaretrovirus-specific epitopes comprising at least 7 contiguous amino acids according to any one of SEQ ID Nos. 1-36, and measuring the production of immune effectors by the immune effector-producing cells, wherein production of the immune effectors by the immune effector-producing cells determines risk and/or presence of betaretrovirus infection in the subject. Isolated peptides and kits for carrying out the methods are also described. |
| priorityDate |
2018-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |